Scientific and Clinical Studies
Theralac® Probiotic Strains

Scientific and Clinical Studies

Theralac® Probiotic Strains

Lactobacillus rhamnosus strain LR-44 present in Theralac® at 2 Billion CFU Per Capsule

References:

Deposited at the American Type Culture Collection (ATCC) as
SD5217.

Collins, M.D., Phillips, B.A. and Zanoni, P. (1989).
Deoxy-ribonucleic acid homology studies of Lactobacillus
casei, Lactobacillus paracasei sp. nov. subsp. Paracasei and subsp. Tolerans
and Lactobacillus rhamnosus sp. nov.
comb. nov. International Journal of Systemic Bacteriology 39:105-108.

Foligne, B., Nutten, S., Grangette, C., Dennin, V.,
Goudercourt, D., Poiret, S., Dewulf, J., Brassart, D., Mercenier, A. and Pot,
B. (2007). Correlation between in vitro and
in vivo immunomodulatory properties
of lactic acid bacteria. World Journal of Gastroenterology. 13(2):236-243.

Foligne, B., Zoumpopoulou, G., Dewulf, J., Ben Younes, A.,
Chareyre, F., Sirard, J.-C., Pot, B. and Grangette, C. (2007). A Key Role of
Dendritic Cells in Probiotic Functionality. PloS ONE 2(3):e313.
doi:10.137l/journal.pone.0000313.

List of taxonomic units proposed for QPS status http://www.efsa.europe.eu/EFSA/Scientific_Opinion/sc_op_ej587_gps_en.pdf.

Return to Scientific References